CD274 and neoplasm: However, combined treatment with single specific antibodies and NPs exerted antitumor effects only at an early stage, and tumor relapse eventually occurred, which indicated that PmTriTNE could prevent solid tumor immunotherapy resistance, probably due to enhanced tumor binding by targeting dual TAAs and the synergistic effects of both PD‐L1 blockade and T‐cell redirection.